@article{475cea15d36f4875b26bac6282379c77,
title = "Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study",
keywords = "apolipoprotein C3, atherogenic dyslipidaemia, de novo lipogenesis, GLP-1-agonist, liraglutide, liver fat, postprandial lipids, remnant lipoproteins, FATTY LIVER-DISEASE, REMNANT CHOLESTEROL, VILDAGLIPTIN THERAPY, RECEPTOR AGONISTS, TRIGLYCERIDE, LIPOPROTEINS, METFORMIN, EXENATIDE, PARTICLES, PLACEBO, 3121 General medicine, internal medicine and other clinical medicine",
author = "Niina Matikainen and Sanni S{\"o}derlund and Elias Bj{\"o}rnson and Kirsi Pietil{\"a}inen and Antti Hakkarainen and Nina Lundbom and Marja-Riitta Taskinen and Jan Boren",
year = "2019",
month = jan,
doi = "10.1111/dom.13487",
language = "English",
volume = "21",
pages = "84--94",
journal = "Diabetes, obesity and metabolism",
issn = "1462-8902",
publisher = "Wiley",
number = "1",
}